What is the next best step in management for a 67-year-old man with prior myocardial infarction treated with percutaneous coronary intervention, hypertension, dyslipidemia, and current medications including aspirin, metoprolol, a statin, and an ACE inhibitor/ARB, who presents after an unexplained syncopal episode with normal vital signs, normal physical exam, normal laboratory studies, normal electrocardiogram, normal non‑contrast head CT, and normal echocardiogram?

Monitor on Telemetry Overnight

This patient requires inpatient telemetry monitoring (Option 1) given his high-risk features: prior MI with PCI, unexplained syncope, and chronic left bundle branch block (LBBB). While his initial workup is reassuring, the combination of structural heart disease and syncope of unclear etiology mandates cardiac rhythm surveillance to exclude life-threatening arrhythmias before discharge.

Risk Stratification in Syncope with Cardiac Disease

This 67-year-old man presents with several established high-risk features that predict adverse outcomes after syncope:

• Structural heart disease (prior MI with PCI 5 years ago) 1, 2
• Abnormal baseline ECG (chronic LBBB) - a consistent predictor across multiple syncope risk scores 2
• Male sex and age >65 years - both independent risk factors for serious events 2
• Absence of prodromal symptoms - associated with cardiac rather than vasovagal etiology 2

The 2017 ACC/AHA/HRS Syncope Guidelines emphasize that patients with structural heart disease have a 41% rate of positive findings during evaluation, with 21% having ventricular tachycardia 1. In contrast, patients without cardiac disease have only a 5% positive yield. This patient clearly falls into the high-risk category requiring further evaluation.

Why Not Immediate Discharge?

Outpatient cardiac monitoring (Option 2) is insufficient for several reasons:

1. The chronic LBBB creates diagnostic uncertainty - while unchanged from prior studies, LBBB can mask acute ischemic changes and is associated with increased risk of ventricular arrhythmias 3

2. Initial troponin may be falsely reassuring - the guidelines specifically note that a single troponin measurement is inadequate, and serial measurements over 6-12 hours are required to exclude myocardial injury 3, 4

3. The normal echocardiogram does not exclude arrhythmic syncope - echo primarily assesses structural abnormalities but cannot detect transient rhythm disturbances 1

4. His medications include metoprolol - while beta-blockers are appropriate for his post-MI status 5, 6, 7, 8, they can mask warning symptoms of arrhythmias and may contribute to bradyarrhythmic syncope, particularly in the setting of LBBB

The Role of Telemetry Monitoring

Inpatient telemetry serves multiple critical functions:

• Detects life-threatening arrhythmias - ventricular tachycardia, high-grade AV block, or prolonged pauses that may have caused the syncope 3, 1
• Allows serial troponin measurements - to definitively exclude acute coronary syndrome as the precipitant 3, 4
• Provides safe observation period - during which recurrent symptoms can be immediately evaluated and treated
• Enables medication adjustment if needed - particularly if bradyarrhythmia related to beta-blocker therapy is identified

The 2017 guidelines note that ECG monitoring should be initiated as soon as possible in all patients to detect life-threatening arrhythmias 3. For patients with structural heart disease and unexplained syncope, this monitoring is best performed in the inpatient setting initially.

Why Not CT Pulmonary Angiogram?

Option 4 (CTPA) is not indicated because:

• The patient has no dyspnea, tachycardia, or hypoxemia - key clinical features of pulmonary embolism
• D-dimer is normal - effectively excluding PE in this moderate-risk patient
• The syncope occurred while walking (exertional), not at rest, making cardiac etiology more likely than PE
• No chest pain or pleuritic symptoms were reported

Disposition Algorithm

For this patient with cardiac syncope:

1. Admit for telemetry monitoring (24-48 hours minimum)

2. Obtain serial troponins at 0,3-6, and 12 hours to exclude MI

3. Continue telemetry to capture any arrhythmic events

4. If monitoring reveals:

   • Ventricular arrhythmias → Consider electrophysiology study and possible ICD placement 1
   • High-grade AV block or pauses → Consider pacemaker evaluation
   • Ischemic changes → Proceed to coronary angiography
   • No abnormalities detected → Consider outpatient event monitor after discharge and possible stress testing

5. Optimize secondary prevention medications - ensure he's on appropriate doses of beta-blocker, ACE inhibitor/ARB, statin, and antiplatelet therapy per post-MI guidelines 5, 6, 7, 8, 6

Common Pitfalls to Avoid

• Don't be falsely reassured by a single normal troponin - serial measurements are mandatory 3
• Don't discharge based solely on normal initial testing - structural heart disease changes the risk calculus entirely 1, 2
• Don't assume LBBB is "chronic and stable" without excluding acute changes - comparison with truly old ECGs is essential 3
• Don't overlook medication effects - beta-blockers can contribute to bradyarrhythmic syncope, especially with underlying conduction disease

The combination of prior MI, LBBB, and unexplained syncope creates sufficient risk to warrant inpatient observation with continuous cardiac monitoring before any consideration of discharge.